# FDA Inspection 1175325 - Aspire Fertility Institute McAllen - July 12, 2022

Source: https://www.keypedia.com/records/fda_inspections/aspire-fertility-institute-mcallen/21e1ddd0-04e5-4488-bf29-8430d82daad9
Source feed: FDA_Inspections

> FDA Inspection 1175325 for Aspire Fertility Institute McAllen on July 12, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1175325
- Company Name: Aspire Fertility Institute McAllen
- Inspection Date: 2022-07-12
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1277627 - 2025-07-22](https://www.keypedia.com/records/fda_inspections/aspire-fertility-institute-mcallen/13eb47df-be86-4469-ade3-1f6a316d7aae)
- [FDA Inspection 1277627 - 2025-07-22](https://www.keypedia.com/records/fda_inspections/aspire-fertility-institute-mcallen/6d2c8278-2afb-47e0-88db-c3f2b0c10c98)
- [FDA Inspection 1175325 - 2022-07-12](https://www.keypedia.com/records/fda_inspections/aspire-fertility-institute-mcallen/5b5ee8bc-f057-4e64-9cfd-93aeb0af84a3)
- [FDA Inspection 1076436 - 2018-12-17](https://www.keypedia.com/records/fda_inspections/aspire-fertility-institute-mcallen/f5304b77-4b16-4d1e-88c1-40987d079c2d)

Company: https://www.keypedia.com/companies/aspire-fertility-institute-mcallen/75ec5423-c468-4df6-858a-1c12e58965ce

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d